CrossBridge Bio secures $10 million financing to advance the development of next-generation dual-payload ADC therapies

BigHat unveils next-gen ADC designed with Lonza’s Synaffix as lead program

AstraZeneca to build Antibody Drug Conjugate (ADC) manufacturing facility in Singapore

ADC Therapeutics axes lead solid tumor drug after phase 1 setback, pivots to preclinical programs

NextCure reports preclinical data for LNCB74 and additional clinical biomarker data for NC410 combo at...

Celltrion unveils development of two cancer drugs

MacroGenics pauses work on vobra duo ADC pending mature survival data